Piramal Pharma Solutions (PPS) has recently reported significant achievements in customer audits and regulatory approvals, marking a pivotal year for the company. Over the past fiscal year, PPS completed more than 200 customer audits and secured over 70 approvals from various regulatory bodies globally, highlighting its commitment to quality and operational excellence.
This accomplishment is rooted in PPS's comprehensive quality strategy, which emphasizes sustained compliance and continuous improvement through robust governance and workforce development. The company has implemented innovative measures, such as predictive quality tools and specialized training programs, to enhance audit readiness and operational efficiency. These initiatives aim to proactively meet evolving regulatory standards while ensuring high-quality production processes.
Digital transformation plays a crucial role in PPS's strategy, with platforms like eLab and exForms automating laboratory processes and digitizing compliance forms. These tools not only improve efficiency but also enhance the predictability of outcomes, thereby supporting rigorous quality control. Additionally, the introduction of AI-enabled tools like iAssist is streamlining investigations, ensuring consistency, and reducing manual workload for teams.
According to Rashida Najmi, Chief Quality Officer at PPS, the company's focus on integrating quality into daily operations ensures that audit readiness is a continuous priority. This disciplined approach not only meets customer expectations but also reinforces PPS's reputation as a reliable partner in the pharmaceutical industry. The successful track record in audits underscores PPS's long-standing commitment to delivering safe and effective therapies globally.